Search Records

Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.

The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under Interim Order (IO) No. 2.

Some Canadians are at risk of developing severe complications from an illness due to underlying medical conditions and age. If you are at risk for complications, you can take action to reduce your risk of getting sick from COVID-19.

The Government of Canada and the Canadian Pain Task Force (CPTF) recognize Canadians living with chronic pain need additional supports during COVID-19. The following list of supportive resources was assembled in collaboration with stakeholders and may be used by you and your partners in care to...

During the COVID-19 pandemic, the CFIA is delivering critical services that protect food safety, animal health, plant health and market access. Appropriate oversight of domestic production and imported food products are essential to providing safe food for consumers while supporting trade and the...